دورية أكاديمية

Optimization and validation of mitochondria-based functional assay as a useful tool to identify BH3-like molecules selectively targeting anti-apoptotic Bcl-2 proteins

التفاصيل البيبلوغرافية
العنوان: Optimization and validation of mitochondria-based functional assay as a useful tool to identify BH3-like molecules selectively targeting anti-apoptotic Bcl-2 proteins
المؤلفون: Long, Jianting, Liu, Liu, Nikolovska-Coleska, Zaneta, Shangary, Sanjeev, Yi, Han, Wang, Shenming, Wang, Shaomeng
بيانات النشر: BioMed Central Ltd.
سنة النشر: 2013
المجموعة: BioMed Central
مصطلحات موضوعية: Mitochondrion, B cell lymphoma 2 (Bcl-2), Bcl-2 homolog domain 3 (BH3), Mitochondrial outer membrane permeabilization (MOMP)
الوصف: Background Mitochondrial outer membrane permeabilization (MOMP) is a crucial step leading to apoptotic destruction of cancer cells. Bcl-2 family proteins delicately regulate mitochondrial outer membrane integrity through protein-protein interactions, which makes the mitochondrion an ideal cell-free system for screening molecules targeting the Bcl-2 anti-apoptotic proteins. But assay conditions need to be optimized for more reliable results. In this study, we aimed at establishing a reliable functional assay using mitochondria isolated from breast cancer cells to decipher the mode of action of BH3 peptides derived from BH3-only proteins. In this study, high ionic strength buffer was adopted during the initiation of MOMP. Mitochondria isolated from human breast cancer cell lines with distinct expression patterns of Bcl-2 anti-apoptotic proteins were permeabilized by different BH3 peptides alone or in combination, with or without the presence of recombinant anti-apoptotic Bcl-2 family proteins. Cytochrome C and Smac/Diablo were tested in both supernatants and mitochondrial pellets by Western blotting. Results Sufficient ionic strength was required for optimal release of Cytochrome C. Bad and Noxa BH3 peptides exhibited their bona fide antagonistic effects against Bcl-2/Bcl-xL and Mcl-1 proteins, respectively, whereas Bim BH3 peptide antagonized all three anti-apoptotic Bcl-2 members. Bad and Noxa peptides synergized with each other in the induction of MOMP when mitochondria were dually protected by both Bcl-2/Bcl-xL and Mcl-1. Conclusions This method based on MOMP is a useful screening tool for identifying BH3 mimetics with selective toxicity against breast cancer cell mitochondria protected by the three major Bcl-2 anti-apoptotic proteins.
نوع الوثيقة: article in journal/newspaper
اللغة: English
العلاقة: http://www.biomedcentral.com/1472-6750/13/45Test
الإتاحة: http://www.biomedcentral.com/1472-6750/13/45Test
حقوق: Copyright 2013 Long et al.; licensee BioMed Central Ltd.
رقم الانضمام: edsbas.28BDD97A
قاعدة البيانات: BASE
ResultId 1
Header edsbas
BASE
edsbas.28BDD97A
847
3
Academic Journal
academicJournal
846.889038085938
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsbas&AN=edsbas.28BDD97A&custid=s6537998&authtype=sso
FullText Array ( [Availability] => 0 )
Array ( [0] => Array ( [Url] => http://www.biomedcentral.com/1472-6750/13/45# [Name] => EDS - BASE [Category] => fullText [Text] => View record in BASE [MouseOverText] => View record in BASE ) )
Items Array ( [Name] => Title [Label] => Title [Group] => Ti [Data] => Optimization and validation of mitochondria-based functional assay as a useful tool to identify BH3-like molecules selectively targeting anti-apoptotic Bcl-2 proteins )
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Long%2C+Jianting%22">Long, Jianting</searchLink><br /><searchLink fieldCode="AR" term="%22Liu%2C+Liu%22">Liu, Liu</searchLink><br /><searchLink fieldCode="AR" term="%22Nikolovska-Coleska%2C+Zaneta%22">Nikolovska-Coleska, Zaneta</searchLink><br /><searchLink fieldCode="AR" term="%22Shangary%2C+Sanjeev%22">Shangary, Sanjeev</searchLink><br /><searchLink fieldCode="AR" term="%22Yi%2C+Han%22">Yi, Han</searchLink><br /><searchLink fieldCode="AR" term="%22Wang%2C+Shenming%22">Wang, Shenming</searchLink><br /><searchLink fieldCode="AR" term="%22Wang%2C+Shaomeng%22">Wang, Shaomeng</searchLink> )
Array ( [Name] => Publisher [Label] => Publisher Information [Group] => PubInfo [Data] => BioMed Central Ltd. )
Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2013 )
Array ( [Name] => Subset [Label] => Collection [Group] => HoldingsInfo [Data] => BioMed Central )
Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22Mitochondrion%22">Mitochondrion</searchLink><br /><searchLink fieldCode="DE" term="%22B+cell+lymphoma+2+%28Bcl-2%29%22">B cell lymphoma 2 (Bcl-2)</searchLink><br /><searchLink fieldCode="DE" term="%22Bcl-2+homolog+domain+3+%28BH3%29%22">Bcl-2 homolog domain 3 (BH3)</searchLink><br /><searchLink fieldCode="DE" term="%22Mitochondrial+outer+membrane+permeabilization+%28MOMP%29%22">Mitochondrial outer membrane permeabilization (MOMP)</searchLink> )
Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => Background Mitochondrial outer membrane permeabilization (MOMP) is a crucial step leading to apoptotic destruction of cancer cells. Bcl-2 family proteins delicately regulate mitochondrial outer membrane integrity through protein-protein interactions, which makes the mitochondrion an ideal cell-free system for screening molecules targeting the Bcl-2 anti-apoptotic proteins. But assay conditions need to be optimized for more reliable results. In this study, we aimed at establishing a reliable functional assay using mitochondria isolated from breast cancer cells to decipher the mode of action of BH3 peptides derived from BH3-only proteins. In this study, high ionic strength buffer was adopted during the initiation of MOMP. Mitochondria isolated from human breast cancer cell lines with distinct expression patterns of Bcl-2 anti-apoptotic proteins were permeabilized by different BH3 peptides alone or in combination, with or without the presence of recombinant anti-apoptotic Bcl-2 family proteins. Cytochrome C and Smac/Diablo were tested in both supernatants and mitochondrial pellets by Western blotting. Results Sufficient ionic strength was required for optimal release of Cytochrome C. Bad and Noxa BH3 peptides exhibited their bona fide antagonistic effects against Bcl-2/Bcl-xL and Mcl-1 proteins, respectively, whereas Bim BH3 peptide antagonized all three anti-apoptotic Bcl-2 members. Bad and Noxa peptides synergized with each other in the induction of MOMP when mitochondria were dually protected by both Bcl-2/Bcl-xL and Mcl-1. Conclusions This method based on MOMP is a useful screening tool for identifying BH3 mimetics with selective toxicity against breast cancer cell mitochondria protected by the three major Bcl-2 anti-apoptotic proteins. )
Array ( [Name] => TypeDocument [Label] => Document Type [Group] => TypDoc [Data] => article in journal/newspaper )
Array ( [Name] => Language [Label] => Language [Group] => Lang [Data] => English )
Array ( [Name] => NoteTitleSource [Label] => Relation [Group] => SrcInfo [Data] => http://www.biomedcentral.com/1472-6750/13/45 )
Array ( [Name] => URL [Label] => Availability [Group] => URL [Data] => http://www.biomedcentral.com/1472-6750/13/45 )
Array ( [Name] => Copyright [Label] => Rights [Group] => Cpyrght [Data] => Copyright 2013 Long et al.; licensee BioMed Central Ltd. )
Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsbas.28BDD97A )
RecordInfo Array ( [BibEntity] => Array ( [Languages] => Array ( [0] => Array ( [Text] => English ) ) [Subjects] => Array ( [0] => Array ( [SubjectFull] => Mitochondrion [Type] => general ) [1] => Array ( [SubjectFull] => B cell lymphoma 2 (Bcl-2) [Type] => general ) [2] => Array ( [SubjectFull] => Bcl-2 homolog domain 3 (BH3) [Type] => general ) [3] => Array ( [SubjectFull] => Mitochondrial outer membrane permeabilization (MOMP) [Type] => general ) ) [Titles] => Array ( [0] => Array ( [TitleFull] => Optimization and validation of mitochondria-based functional assay as a useful tool to identify BH3-like molecules selectively targeting anti-apoptotic Bcl-2 proteins [Type] => main ) ) ) [BibRelationships] => Array ( [HasContributorRelationships] => Array ( [0] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Long, Jianting ) ) ) [1] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Liu, Liu ) ) ) [2] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Nikolovska-Coleska, Zaneta ) ) ) [3] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Shangary, Sanjeev ) ) ) [4] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Yi, Han ) ) ) [5] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Wang, Shenming ) ) ) [6] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Wang, Shaomeng ) ) ) ) [IsPartOfRelationships] => Array ( [0] => Array ( [BibEntity] => Array ( [Dates] => Array ( [0] => Array ( [D] => 01 [M] => 01 [Type] => published [Y] => 2013 ) ) [Identifiers] => Array ( [0] => Array ( [Type] => issn-locals [Value] => edsbas ) [1] => Array ( [Type] => issn-locals [Value] => edsbas.oa ) ) ) ) ) ) )
IllustrationInfo